Peter Radovich's most recent trade in Mirum Pharmaceuticals Inc was a trade of 14,440 Common Stock done . Disclosure was reported to the exchange on March 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mirum Pharmaceuticals Inc | Peter Radovich | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 14,440 | 26,551 (0%) | 0% | - | Common Stock | |
| Mirum Pharmaceuticals Inc | Peter Radovich | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 14,440 | 7,220 | - | - | Performance Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Peter Radovich | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 44.21 per share. | 15 Mar 2025 | 7,879 | 18,672 (0%) | 0% | 44.2 | 348,364 | Common Stock |
| Mirum Pharmaceuticals Inc | Peter Radovich | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 45.57 per share. | 04 Mar 2025 | 13,681 | 13,280 (0%) | 0% | 45.6 | 623,458 | Common Stock |
| Mirum Pharmaceuticals Inc | Peter Radovich | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 45.74 per share. | 04 Mar 2025 | 1,169 | 12,111 (0%) | 0% | 45.7 | 53,470 | Common Stock |
| Mirum Pharmaceuticals Inc | Peter Radovich | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 48.22 per share. | 03 Feb 2025 | 2,627 | 26,961 (0%) | 0% | 48.2 | 126,681 | Common Stock |
| Mirum Pharmaceuticals Inc | Peter Radovich | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2025 | 5,750 | 32,765 (0%) | 0% | - | Common Stock | |
| Mirum Pharmaceuticals Inc | Peter Radovich | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2025 | 5,750 | 11,500 | - | - | Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Peter Radovich | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 47.92 per share. | 23 Jan 2025 | 3,177 | 29,588 (0%) | 0% | 47.9 | 152,256 | Common Stock |
| Mirum Pharmaceuticals Inc | Peter Radovich | PRESIDENT AND COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Peter Radovich | PRESIDENT AND COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 21,660 | 21,660 | - | - | Performance Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Peter Radovich | PRESIDENT AND COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 12,500 | 12,500 | - | - | Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Peter Radovich | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 42.82 per share. | 07 Jan 2025 | 1,998 | 27,015 (0%) | 0% | 42.8 | 85,545 | Common Stock |
| Mirum Pharmaceuticals Inc | Peter Radovich | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 25.80 per share. | 25 Mar 2024 | 4,303 | 29,013 (0%) | 0% | 25.8 | 111,017 | Common Stock |
| Mirum Pharmaceuticals Inc | Peter Radovich | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 26.19 per share. | 02 Feb 2024 | 1,790 | 34,695 (0%) | 0% | 26.2 | 46,883 | Common Stock |
| Mirum Pharmaceuticals Inc | Radovich Peter | PRESIDENT AND COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Peter Radovich | PRESIDENT AND COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 17,250 | 17,250 | - | - | Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Radovich Peter | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 28.03 per share. | 08 Jan 2024 | 1,408 | 36,485 (0%) | 0% | 28.0 | 39,473 | Common Stock |
| Mirum Pharmaceuticals Inc | Peter Radovich | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 22.29 per share. | 10 Nov 2023 | 218 | 37,893 (0%) | 0% | 22.3 | 4,859 | Common Stock |
| Mirum Pharmaceuticals Inc | Peter Radovich | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 25.65 per share. | 03 Jul 2023 | 1,425 | 37,675 (0%) | 0% | 25.6 | 36,546 | Common Stock |
| Mirum Pharmaceuticals Inc | Peter Radovich | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 16.92 per share. | 10 May 2023 | 968 | 39,100 (0%) | 0% | 16.9 | 16,382 | Common Stock |
| Mirum Pharmaceuticals Inc | Peter Radovich | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 57,750 | 57,750 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Peter Radovich | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 14,440 | 38,132 (0%) | 0% | 0 | Common Stock | |
| Mirum Pharmaceuticals Inc | Peter Radovich | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 20.62 per share. | 09 Jan 2023 | 1,379 | 33,316 (0%) | 0% | 20.6 | 28,438 | Common Stock |
| Mirum Pharmaceuticals Inc | Peter Radovich | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 17.05 per share. | 10 Nov 2022 | 292 | 23,692 (0%) | 0% | 17.1 | 4,979 | Common Stock |
| Rain Oncology Inc | Peter Radovich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Mirum Pharmaceuticals Inc | Peter Radovich | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 13.57 per share. | 10 May 2022 | 1,169 | 23,400 (0%) | 0% | 13.6 | 15,859 | Common Stock |
| Mirum Pharmaceuticals Inc | Peter Radovich | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Peter Radovich | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 10,000 | 22,231 (0%) | 0% | 0 | Common Stock | |
| Mirum Pharmaceuticals Inc | Peter Radovich | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 13.51 per share. | 10 Nov 2021 | 958 | 12,231 (0%) | 0% | 13.5 | 12,947 | Common Stock |
| Mirum Pharmaceuticals Inc | Peter Radovich | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 14.62 per share. | 10 May 2021 | 1,006 | 4,512 (0%) | 0% | 14.6 | 14,708 | Common Stock |
| Rain Oncology Inc | Peter Radovich | Director | 27 Apr 2021 | 9,500 | 0 | - | - | Series A Preferred Stock | ||
| Rain Oncology Inc | Peter Radovich | Director | 27 Apr 2021 | 8,796 | 8,796 | - | - | Common Stock | ||
| Mirum Pharmaceuticals Inc | Peter Radovich | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 65,000 | 65,000 | - | - | Stock Option (right to buy) |